Format

Send to

Choose Destination
Nat Rev Cancer. 2013 Jul;13(7):443-54. doi: 10.1038/nrc3537. Epub 2013 Jun 13.

End-joining, translocations and cancer.

Author information

1
Rutgers University, Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854, USA. bunting@cabm.rutgers.edu

Abstract

Fusion genes that are caused by chromosome translocations have been recognized for several decades as drivers of deregulated cell growth in certain types of cancer. In recent years, oncogenic fusion genes have been found in many haematological and solid tumours, demonstrating that translocations are a common cause of malignancy. Sequencing approaches have now confirmed that numerous, non-clonal translocations are a typical feature of cancer cells. These chromosome rearrangements are often highly complex and contain DNA sequence from multiple genomic sites. The factors and pathways that promote translocations are becoming clearer, with non-homologous end-joining implicated as a key source of genomic rearrangements.

PMID:
23760025
PMCID:
PMC5724777
DOI:
10.1038/nrc3537
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center